2024 European Society of Cardiology (London)

Samer Al Said – Extracranial systemic embolic events in patients with atrial fibrillation-an individual patient-level meta-analysis of 71 683 patients randomized to NOAC vs warfarin

Tze-Fan Chao – Clinical outcomes in 10,000 Asian vs 61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs-a patient-level meta-analyses from COMBINE AF

Paul Haller – Heart failure risk assessment using biomarkers in patients with atrial fibrillation – Analysis of 32,041 patients from the COMBINE study

Ziad Hijazi – Evaluation of the biomarker-based ABC-AF-bleeding risk score and clinically based bleeding scores in 31,605 patients with atrial fibrillation treated with oral anticoagulation

Sean Jurgens – Pathogenic cardiomyopathy gene variants inform prognosis in atrial fibrillation-results from exome sequencing in over 17,000 patients in TIMI trials

Yumi Kang – Cardiovascular Efficacy of Evolocumab in Patients with Obesity-Updates from FOURIER Trial

Shinwan Kany – Exome sequencing in over 63,000 patients in TIMI trials uncovers pathogenic cardiomyopathy variant carriers with high risk for heart failure and cardiovascular death

Siddharth Patel – Long-acting Factor XI Inhibition and Periprocedural Bleeding

Manasi Tannu – Intracranial Hemorrhage in Patients with Atrial Fibrillation-Insights from COMBINE-AF

TIMI celebrated our 40th anniversary at the ESC in 2024.  Visit the page to see the photo gallery!